These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12367683)

  • 21. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of isosorbide 5-mononitrate in human plasma by liquid chromatography-tandem mass spectrometry using atmospheric pressure photoionization.
    Silva LC; Oliveira LS; Mendes GD; Garcia G; Pereira Ados S; De Nucci G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):302-6. PubMed ID: 16464650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate.
    Taylor IW; Major RM; Chasseaud LF; Taylor T
    Br J Clin Pharmacol; 1984 May; 17(5):585-7. PubMed ID: 6733004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation.
    Gandini R; Cunietti E; Assereto R; Castoldi D; Tofanetti O; Baggio E
    Arzneimittelforschung; 1987 Jul; 37(7):836-9. PubMed ID: 3675680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-acting isosorbide mononitrate.
    Prakash A; Markham A
    Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel micellar per aqueous liquid chromatographic method for simultaneous determination of diltiazem hydrochloride, metoprolol tartrate and isosorbide mononitrate in human serum.
    Li N; Li CL; Lu NW; Dong YM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():90-7. PubMed ID: 25086418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Packed-column supercritical fluid chromatography for the analysis of isosorbide-5-mononitrate and related compounds in bulk substance and tablets.
    Gyllenhaal O; Karlsson A
    J Biochem Biophys Methods; 2000 Jul; 43(1-3):135-46. PubMed ID: 10869672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of isosorbide 5-mononitrate in human plasma by capillary column gas chromatography.
    Straehl P; Galeazzi RL
    J Pharm Sci; 1984 Sep; 73(9):1317-9. PubMed ID: 6491964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High performance liquid chromatography-electrospray ionization mass spectrometric determination of isosorbide 5-mononitrate in human plasma.
    Sun X; Li X; Cai S; Qin F; Lu X; Li F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):323-8. PubMed ID: 16962389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A validated high performance liquid chromatographic method for analysis of nicotine in pure form and from formulations.
    Tambwekar KR; Kakariya RB; Garg S
    J Pharm Biomed Anal; 2003 Jul; 32(3):441-50. PubMed ID: 14565548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
    Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
    Shao Y; Alluri R; Mummert M; Koetter U; Lech S
    J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polarographic determination of isosorbide dinitrate.
    Turner WR; Lenkiewicz RS
    J Pharm Sci; 1976 Jan; 65(1):118-21. PubMed ID: 1255415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
    Waller DG
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple and sensitive gas chromatography method for determination of isosorbide dinitrate and its metabolites in human plasma: application to pharmacokinetics study on oral spray.
    Jiang Z; Wei C; Sun Z; Guo J; Li R; Zhang R; Yuan G; Guo R
    Drug Res (Stuttg); 2014 Feb; 64(2):73-8. PubMed ID: 23904215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
    Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
    Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.